Dr. Brion Randolph is the Medical Director of Hematologic Oncology at Cancer Treatment Centers of America® (CTCA) in Newnan, Georgia and introduced the new LLS initiative, The Myeloma Link Program at the 2017 Blood Cancer Conference. He recently explained the importance of this new program in the fight against blood cancer as a call-in guest during the Georgia Chapter's annual Strike Out Leukemia & Lymphoma Radiothon with 680 The Fan. Myeloma Link is a pilot program in Washington, D.C., and Atlanta, in collaboration with the National Black Church Initiative (NBCI), to raise awareness of Myeloma knowledge and access to latest treatments in African American communities.
“[Multiple Myeloma] disproportionately affects African Americans,” said Dr. Randolph. “Studies are showing that African Americans are 30 to 40 percent less likely to receive a stem cell transplant and therapies for the treatment of their Myeloma. The Myeloma Link Program is aimed at addressing this disparity and [LLS] is partnering with the African American churches to provide more information and education to the community in hopes of closing that gap.”
Dr. Randolph joined the Georgia Board in 2017. He is a two-time Team In Training teammate and a 2015 Man of the Year candidate for Atlanta, raising over $100,000. He has been a Blood Cancer Conference thought leader and speaker and has helped in securing Cancer Treatment Centers of America as the presenting sponsor for the last 3 years. Dr. Randolph has invested personal time and energy into the Myeloma Link project and provides information in the Myeloma Sunday program videos.